• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Emerging investigators series: ultraviolet and free chlorine aqueous-phase advanced oxidation process: kinetic simulations and experimental validation?
  Divya Kamath,Daisuke Minakata Environ. Sci.: Water Res. Technol., 2018,4, 1231-1238
• 3. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 4. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 5. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azaspirodecane derivatives Azaspirodecane derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azaspirodecane derivatives

Introduction to 8-Methyl-2,8-diazaspiro[4.5]decan-3-one (CAS No. 154495-67-7)

8-Methyl-2,8-diazaspiro[4.5]decan-3-one, with the CAS number 154495-67-7, is a synthetic compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural properties and potential therapeutic applications. This compound belongs to the class of spirocyclic compounds, which are characterized by a central spiro atom connecting two rings. The spirocyclic structure imparts distinct conformational rigidity and chemical stability, making it an attractive scaffold for drug design and development.

The chemical structure of 8-Methyl-2,8-diazaspiro[4.5]decan-3-one consists of a spirocyclic core with a methyl group at the 8-position and a ketone functional group at the 3-position. The presence of these functional groups contributes to its pharmacological properties and reactivity. Recent studies have highlighted the importance of spirocyclic compounds in various therapeutic areas, including central nervous system (CNS) disorders, cancer, and inflammatory diseases.

In the context of medicinal chemistry, 8-Methyl-2,8-diazaspiro[4.5]decan-3-one has been investigated for its potential as a modulator of G protein-coupled receptors (GPCRs). GPCRs are a large family of membrane receptors that play crucial roles in cellular signaling pathways and are implicated in numerous diseases. The ability of this compound to interact with GPCRs makes it a promising candidate for developing novel therapeutic agents.

One of the key areas of research involving 8-Methyl-2,8-diazaspiro[4.5]decan-3-one is its potential as an anxiolytic agent. Anxiety disorders are prevalent mental health conditions that affect millions of people worldwide. Traditional anxiolytics, such as benzodiazepines, have limitations due to their side effects and potential for abuse. Therefore, there is a need for safer and more effective alternatives. Studies have shown that 8-Methyl-2,8-diazaspiro[4.5]decan-3-one exhibits anxiolytic-like effects in animal models without causing significant sedation or cognitive impairment.

Beyond its anxiolytic properties, 8-Methyl-2,8-diazaspiro[4.5]decan-3-one has also been explored for its anti-inflammatory effects. Inflammation is a complex biological response to injury or infection and is involved in many chronic diseases such as arthritis and cardiovascular disease. Research has demonstrated that this compound can inhibit the production of pro-inflammatory cytokines and reduce inflammation in vitro and in vivo models.

The pharmacokinetic properties of 8-Methyl-2,8-diazaspiro[4.5]decan-3-one have been extensively studied to understand its bioavailability, distribution, metabolism, and excretion (ADME). These studies have shown that the compound has favorable pharmacokinetic profiles, including good oral bioavailability and low toxicity. These characteristics make it suitable for further development as a therapeutic agent.

In addition to its therapeutic potential, 8-Methyl-2,8-diazaspiro[4.5]decan-3-one has also been used as a building block in organic synthesis due to its versatile reactivity and ease of functionalization. This makes it a valuable intermediate for synthesizing more complex molecules with diverse biological activities.

The synthesis of 8-Methyl-2,8-diazaspiro[4.5]decan-3-one involves several steps, including the formation of the spirocyclic core through intramolecular cyclization reactions followed by functional group modifications to introduce the desired substituents. Recent advancements in synthetic methods have led to more efficient and scalable routes for producing this compound, facilitating its use in both academic research and industrial applications.

In conclusion, 8-Methyl-2,8-diazaspiro[4.5]decan-3-one (CAS No. 154495-67-7) is a promising compound with diverse applications in medicinal chemistry and organic synthesis. Its unique structural features and favorable pharmacological properties make it an attractive candidate for further research and development as a potential therapeutic agent for various diseases. Ongoing studies continue to explore its full potential and optimize its use in clinical settings.

• 717884-84-9(HEXATRIACONTANAMIDE, N-[2-(1-METHYL-3-PYRROLIDINYL)ETHYL]-)
• 717884-41-8(HEPTADECANAMIDE, N-[2-(1-METHYL-3-PYRROLIDINYL)ETHYL]-)
• 1353506-68-9(2-Methyl-2,8-diazaspiro[4.5]decan-3-one)
• 139726-90-2(1-[(piperidin-4-yl)methyl]pyrrolidin-2-one)
• 150627-27-3(1-Azabicyclo[3.2.1]octan-2-one(9CI))
• 717884-25-8(DECANAMIDE, N-[2-(1-METHYL-3-PYRROLIDINYL)ETHYL]-)
• 717884-29-2(DODECANAMIDE, N-[2-(1-METHYL-3-PYRROLIDINYL)ETHYL]-)
• 717884-57-6(HENEICOSANAMIDE, N-[2-(1-METHYL-3-PYRROLIDINYL)ETHYL]-)
• 717884-55-4(EICOSANAMIDE, N-[2-(1-METHYL-3-PYRROLIDINYL)ETHYL]-)
• 561314-57-6(2,8-Diazaspiro[4.5]decan-3-one)